Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in Columbus, OH
NPI: 1205812997Primary Practice Location
The Eye Center of Columbus, LLC
262 Neil Ave, Columbus, OH
Primary Employer
Eye Physicians, LLC
theeyephysicians.com
HQ Phone
Get M.D. Alice's Phone Numberphone_androidMobile
Get M.D. Alice's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92250Photography of the retina | 484 | 509 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 256 | 263 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 234 | 274 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 163 | 173 |
| 5 | 92136Measurement of corneal curvature and depth of eye | 104 | 104 |
Axial length measurement acquisition rates of two optical biometers in cataractous eyes.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Clin Ophthalmol
Publication Date: 2014-07-22
Evaluation of a New Controlled Point Source LED Glare Tester for Disability Glare Detection in Participants With and Without Cataracts.
Authors: Francis Price, Nicole Fram, Robert Stulting
Publication Date: 2014-07-15
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 1.0%, DRUG: KPI-121 0.25%, DRUG: KPI-121 1.0%, DRUG: Vehicle of KPI-121 0.25%
Lead Sponsor: Ocular Therapeutix, Inc.
Intervention / Treatment: DRUG: Dexamethasone, OTHER: Placebo Vehicle
